norethindrone and Germinoblastoma

norethindrone has been researched along with Germinoblastoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brice, P; Bron, D; Casasnovas, O; De Maertelaer, V; Dechene, J; Demeestere, I; Dupuis, J; Englert, Y; Kentos, A; Peccatori, FA; Van Den Neste, E; Zachee, P	1
Brice, P; Bron, D; Casasnovas, RO; De Maertelaer, V; Dechene, J; Demeestere, I; Englert, Y; Gaillard, I; Kentos, A; Peccatori, FA; Van Den Neste, E; Zachee, P	1

Trials

2 trial(s) available for norethindrone and Germinoblastoma

Article	Year
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 08-01, Volume: 34, Issue:22 Topics: Adult; Female; Fertility; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Lymphoma; Middle Aged; Norethindrone; Ovary; Primary Ovarian Insufficiency; Prospective Studies; Triptorelin Pamoate	2016
Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-01, Volume: 31, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Luteolytic Agents; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Norethindrone; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Time Factors; Treatment Failure; Triptorelin Pamoate	2013

Article

Year

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 08-01, Volume: 34, Issue:22

Topics: Adult; Female; Fertility; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Lymphoma; Middle Aged; Norethindrone; Ovary; Primary Ovarian Insufficiency; Prospective Studies; Triptorelin Pamoate

2016

Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Mar-01, Volume: 31, Issue:7

Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Luteolytic Agents; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Norethindrone; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Time Factors; Treatment Failure; Triptorelin Pamoate

2013